Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).

Pozzan C, Cardin R, Piciocchi M, Cazzagon N, Maddalo G, Vanin V, Giacomin A, Pontisso P, Cillo U, Farinati F.

J Gastroenterol Hepatol. 2014 Aug;29(8):1637-44. doi: 10.1111/jgh.12576.

PMID:
24635038
2.

Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.

Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegn├╣ L, Calabrese F, Gatta A, Pontisso P, Fassina G.

Cancer. 2005 Jun 15;103(12):2558-65.

3.

Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.

Mossad NA, Mahmoud EH, Osman EA, Mahmoud SH, Shousha HI.

Tumour Biol. 2014 Nov;35(11):11559-64. doi: 10.1007/s13277-014-2467-y. Epub 2014 Aug 17.

PMID:
25129443
4.

Diagnostic and prognostic value of alpha-fetoprotein, des-╬│-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.

Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, Toro A, Malaguarnera M, Clementi S, Bertino N, Di Carlo I.

Minerva Med. 2011 Oct;102(5):363-71. Review.

PMID:
22193346
5.

Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.

Biasiolo A, Tono N, Zaninotto M, Merkel C, Fassina G, Plebani M, Gatta A, Pontisso P.

J Med Virol. 2013 Jun;85(6):1005-8. doi: 10.1002/jmv.23493.

PMID:
23588726
6.

Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.

Hussein MM, Ibrahim AA, Abdella HM, Montasser IF, Hassan MI.

Indian J Cancer. 2008 Oct-Dec;45(4):167-72.

7.

Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.

Zuin J, Veggiani G, Pengo P, Gallotta A, Biasiolo A, Tono N, Gatta A, Pontisso P, Toth R, Cerin D, Frecer V, Meo S, Gion M, Fassina G, Beneduce L.

Clin Chem Lab Med. 2010 Feb;48(2):217-23. doi: 10.1515/CCLM.2010.044.

PMID:
20001440
8.

Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.

Guarino M, Di Costanzo GG, Gallotta A, Tortora R, Paneghetti L, Auriemma F, Tuccillo C, Fassina G, Caporaso N, Morisco F.

Scand J Clin Lab Invest. 2017 Oct;77(6):448-453. doi: 10.1080/00365513.2017.1336569. Epub 2017 Jun 13.

PMID:
28609160
9.

Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.

Yu J, Wang ZJ, Chen LH, Dong WZ.

Scand J Clin Lab Invest. 2017 Feb;77(1):8-14. Epub 2016 Oct 20. Review.

PMID:
27762143
10.

Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients.

Bui Huu H, Ha Thuc N, Thi Le HP, Thi Thanh TD, Luong Bac A, Tiribelli C, Pontisso P, Gallotta A, Paneghetti L, Fassina G.

Scand J Clin Lab Invest. 2018 May;78(3):204-210. doi: 10.1080/00365513.2018.1432072. Epub 2018 Jan 30.

PMID:
29381084
11.

Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.

Giannelli G, Fransvea E, Trerotoli P, Beaugrand M, Marinosci F, Lupo L, Nkontchou G, Dentico P, Antonaci S.

Clin Chim Acta. 2007 Aug;383(1-2):147-52. Epub 2007 May 26.

PMID:
17582392
12.

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.

Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, Trerotoli P, Giannelli G, Manas D, Reeves H.

BMC Cancer. 2008 Jul 18;8:200. doi: 10.1186/1471-2407-8-200.

13.

Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?

Montagnana M, Danese E, Lippi G.

Clin Chim Acta. 2015 May 20;445:161-6. doi: 10.1016/j.cca.2015.03.031. Epub 2015 Apr 1. Review.

PMID:
25840050
14.

Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study.

Schmilovitz-Weiss H, Tobar A, Halpern M, Levy I, Shabtai E, Ben-Ari Z.

Diagn Pathol. 2011 Dec 7;6:121. doi: 10.1186/1746-1596-6-121.

15.

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.

Trerotoli P, Fransvea E, Angelotti U, Antonaci G, Lupo L, Mazzocca A, Mangia A, Antonaci S, Giannelli G.

Mol Cancer. 2009 May 27;8:29. doi: 10.1186/1476-4598-8-29.

16.

Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.

Pontisso P, Quarta S, Caberlotto C, Beneduce L, Marino M, Bernardinello E, Tono N, Fassina G, Cavalletto L, Gatta A, Chemello L.

Int J Cancer. 2006 Aug 15;119(4):735-40.

17.

Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.

Jiang J, Wu C, Shen Y, Xu B, Zheng X, Li X, Xu N.

Anticancer Res. 2011 Feb;31(2):687-91.

PMID:
21378357
18.

Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.

Jingting J, Changping W, Ning X, yibei Z, Jun W, Mei J, Bin X, Peter NE, Xueguan Z.

J Clin Lab Anal. 2009;23(4):213-8. doi: 10.1002/jcla.20321.

PMID:
19623644
19.

Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma.

Soyemi OM, Otegbayo JA, Ola SO, Akere A, Soyemi T.

BMC Res Notes. 2012 Aug 3;5:403. doi: 10.1186/1756-0500-5-403.

20.

Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.

Biasiolo A, Trotta E, Fasolato S, Ruvoletto M, Martini A, Gallotta A, Fassina G, Angeli P, Gatta A, Pontisso P.

Dig Liver Dis. 2016 Feb;48(2):197-202. doi: 10.1016/j.dld.2015.10.022. Epub 2015 Oct 31.

PMID:
26614642

Supplemental Content

Support Center